The effect of uroacitide on the proliferation and differentiation of human endometrial carcinoma cell line EAC

Chinese Journal of Clinical Oncology

Volumn 35, Issue 5, 2008, Pages 290-292

  Jia, Jinping ^a   Zhong, Xueyun ^a   Lin, Chenli ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

CDA 2; Differentiation; Endometrial carcinoma; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; UROACETIDE;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; RADIOIMMUNOASSAY;

EID: 77951659493     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108
2. Yao CJ, Lai GM, Chan CF, et al. Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal - regulated kinase signaling pathway[J]. J Altern Complement Med, 2005, 11(5): 903-908
3. Liu JW, Tang Y, Shen Y, et al. Synergistic effect of cell differential anent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells[J]. World J Gastroenterol, 2003, 9 (1): 65-68 (Pubitemid 36131280)
4. Wu RC, Li X, Schonthal AH. Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor [J]. Mol Cell Biochem, 2000, 203(1-2): 59-71 (Pubitemid 30111777)
5. Bokhman JV. Two pathogenetic types of endometrial carcinoma [J]. Gynecol Oncol, 1983, 15(1):10-17